Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas is a research paper published in Journal of Clinical Investigation (2025). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 CA214812,P30 CA08748,T32 GM007739
NCI NIH HHS
Grant: R35 CA197745
NCI NIH HHS
Grant: U01 CA272610
NCI NIH HHS
Grant: R01 CA214812
NCI NIH HHS
Grant: P30 CA008748
NIGMS NIH HHS
Grant: T32 GM007739
NIH HHS
Grant: S10 OD012351
NIH HHS
Grant: S10 OD021764
NIH HHS
Grant: S10 OD032433
National Institutes of Health
Grant: 1R01CA214812-01A1
Structure and function of genome plasticity in human cancer
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5T32GM007739-30
Weill Cornell/Rockefeller/Sloan-Kettering MST Program
FWCI
2.04
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals